Sun Pharma receives tentative USFDA approval for generic Crestor

30 Sep 2010

1

Mumbai-based Sun Pharmaceutical Industries Ltd has announced that the US FDA has granted its US subsidiary a tentative approval for its abbreviated new drug application (ANDA) to market a generic version of IPR Pharmaceutical's Crestor tablets in dosage forms of 5mg, 10mg, 20mg and 40mg.

These generic rosuvastatin tablets contain rosuvastatin calcium in 5mg, 10mg, 20mg and 40mg dosages.

Generic rosuvastatin calcium tablets are indicated in patients with hypertriglyceridemia as an adjunct to diet and patients with homozygous familial hypercholesterolemia.

Crestor has annual sale of approximately $ 3.4 billion in the US.

Crestor is licensed from Japan's Shionogi & Co, Ltd. Crestor is a registered trademark of the AstraZeneca group of companies.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers